Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
about
OnabotulinumtoxinA for neurogenic detrusor overactivity and dose differences: a systematic reviewSecondary and tertiary treatments for multiple sclerosis patients with urinary symptomsBotulinum toxin-what urologic uses does the data support?The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplastyThe effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA.Onabotulinumtoxin A for treating overactive/poor compliant bladders in children and adolescents with neurogenic bladder secondary to myelomeningoceleOnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity.Treatment of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelinesBotulinum toxin for symptomatic therapy in multiple sclerosis.OnabotulinumtoxinA (Botox(®)): a review of its use in the treatment of urinary incontinence in patients with multiple sclerosis or subcervical spinal cord injury.The evaluation and management of refractory neurogenic overactive bladder.Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.Botulinum Toxin Treatment in Multiple Sclerosis-a Review.Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis.Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI.Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity.Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury.Patient experience and satisfaction with Onabotulinumtoxin A for refractory overactive bladder.Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele
P2860
Q26826756-09DFC2EC-1A48-4D30-8094-8918A3841C21Q28070040-650F42DB-C28B-4B04-95C3-7D3A4271751EQ30620372-16DE048C-B3C3-46C5-8C27-D46A50E00944Q35643253-F89E9780-9521-41EE-BDAF-57E53881FBB4Q35898622-08CE6EC6-A6AA-4DDD-87F0-B5B887961F2BQ36586729-1D959F87-B0EC-4652-830F-8845A12F6881Q37536741-4D7A094A-EB64-4C0D-BE31-EF249D8FBC87Q37720749-962EAC05-E790-4F1C-AC81-2C23EDC3E428Q38222194-9A7AF315-412A-427F-A3EB-35A97E0E74C5Q38233836-12477975-3E05-46B6-BEE5-384E2B5F7C52Q38239522-5A9BC8D7-0FD2-49BE-A248-512ABFD57899Q38508246-A0C759E0-68CC-482C-A1AF-B7121BB7577AQ38618854-66B1CD14-2026-4B56-B776-DEF59D59E42AQ39210488-6A5D3E3D-ECEA-4180-9671-B23E87748DC7Q39823287-4815371E-8193-4526-BE1A-A06598BA8281Q41110077-DA96E4C2-5ECE-47A6-8045-AA3D560220DAQ41412205-4AD4323A-9029-4D9E-8C35-78A12CD46E51Q41670784-126CB9BE-F770-47D3-84DF-AE365DB3FC6BQ58921985-96F16679-576F-4488-9D38-2C273895E5A8
P2860
Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Treatment satisfaction and imp ...... rogenic detrusor overactivity.
@en
Treatment satisfaction and imp ...... rogenic detrusor overactivity.
@nl
type
label
Treatment satisfaction and imp ...... rogenic detrusor overactivity.
@en
Treatment satisfaction and imp ...... rogenic detrusor overactivity.
@nl
prefLabel
Treatment satisfaction and imp ...... rogenic detrusor overactivity.
@en
Treatment satisfaction and imp ...... rogenic detrusor overactivity.
@nl
P2093
P2860
P356
P1476
Treatment satisfaction and imp ...... rogenic detrusor overactivity.
@en
P2093
David Sussman
Denise Globe
Peter Pommerville
Vaishali Patel
P2860
P304
P356
10.1002/NAU.22293
P577
2012-09-10T00:00:00Z